386 related articles for article (PubMed ID: 26797416)
21. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
[TBL] [Abstract][Full Text] [Related]
22. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
23. LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer.
Zheng J; Wang F; Lu S; Wang X
Exp Mol Pathol; 2016 Feb; 100(1):116-24. PubMed ID: 26683818
[TBL] [Abstract][Full Text] [Related]
24. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
[TBL] [Abstract][Full Text] [Related]
25. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
26. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362
[TBL] [Abstract][Full Text] [Related]
27. HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells.
You H; Kong F; Zhou K; Wei X; Hu L; Hu W; Luo W; Kou Y; Liu X; Chen X; Zheng K; Tang R
J Cell Physiol; 2018 Sep; 233(9):7279-7291. PubMed ID: 29600594
[TBL] [Abstract][Full Text] [Related]
28. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma.
Hu YP; Wu ZB; Jiang L; Jin YP; Li HF; Zhang YJ; Ma Q; Ye YY; Wang Z; Liu YC; Chen HZ; Liu YB
Int J Biochem Cell Biol; 2018 Apr; 97():16-27. PubMed ID: 29413947
[TBL] [Abstract][Full Text] [Related]
29. Grb2-associated binder 2 silencing impairs growth and migration of H1975 cells via modulation of PI3K-Akt signaling.
Wang WJ; Mou K; Wu XF; Zhang JZ; Ren G; Qi JD; Xu YF; Yao X
Int J Clin Exp Pathol; 2015; 8(9):10575-84. PubMed ID: 26617767
[TBL] [Abstract][Full Text] [Related]
30. Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells.
Grunewald TG; Kammerer U; Schulze E; Schindler D; Honig A; Zimmer M; Butt E
Exp Cell Res; 2006 Apr; 312(7):974-82. PubMed ID: 16430883
[TBL] [Abstract][Full Text] [Related]
31. Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells.
Tang R; Kong F; Hu L; You H; Zhang P; Du W; Zheng K
Virol J; 2012 Aug; 9():163. PubMed ID: 22897902
[TBL] [Abstract][Full Text] [Related]
32. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.
Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K
Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545
[TBL] [Abstract][Full Text] [Related]
33. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2.
Shen H; Zhan M; Zhang Y; Huang S; Xu S; Huang X; He M; Yao Y; Man M; Wang J
Cell Death Dis; 2018 Jan; 9(2):71. PubMed ID: 29358655
[TBL] [Abstract][Full Text] [Related]
34. Corrigendum to .
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Jun; 376(1):197-198. PubMed ID: 27125425
[No Abstract] [Full Text] [Related]
35. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
[TBL] [Abstract][Full Text] [Related]
36. Investigating lasp-2 in cell adhesion: new binding partners and roles in motility.
Bliss KT; Chu M; Jones-Weinert CM; Gregorio CC
Mol Biol Cell; 2013 Apr; 24(7):995-1006. PubMed ID: 23389630
[TBL] [Abstract][Full Text] [Related]
37. Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer.
Qiu Y; Li X; Yi B; Zheng J; Peng Z; Zhang Z; Wu M; Shen F; Su C
Oncotarget; 2015 Aug; 6(22):19148-62. PubMed ID: 25895131
[TBL] [Abstract][Full Text] [Related]
38. Thioredoxin-1 promotes colorectal cancer invasion and metastasis through crosstalk with S100P.
Lin F; Zhang P; Zuo Z; Wang F; Bi R; Shang W; Wu A; Ye J; Li S; Sun X; Wu J; Jiang L
Cancer Lett; 2017 Aug; 401():1-10. PubMed ID: 28483515
[TBL] [Abstract][Full Text] [Related]
39. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.
Lyu WJ; Shu YJ; Liu YB; Dong P
Chin Med J (Engl); 2020 Oct; 133(19):2321-2329. PubMed ID: 32925281
[TBL] [Abstract][Full Text] [Related]
40. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]